E-Book, Englisch, 409 Seiten, eBook
Pathak Genomics-Driven Healthcare
1. Auflage 2018
ISBN: 978-981-10-7506-3
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark
Trends in Disease Prevention and Treatment
E-Book, Englisch, 409 Seiten, eBook
ISBN: 978-981-10-7506-3
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Chapter 1. Rethinking drug discovery and targeting after the genomic revolution.- Chapter 2. Living between sickness and health: Where is the human genome leading us?.- Chapter 3. Pharmacogenomics: Setting Newer Paradigms of Genetics in Therapy and Medicine.- Chapter 4. Bioinformatics and Pharmacogenomics: Tools to Understand and Accelerate Infectious Disease Control.- Chapter 5. Race and Ethnicity – Understanding Difference in the Genome Era.- Chapter 6. The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases.- Chapter 7. Impact of genomics on drug discovery and clinical medicine.- Chapter 8. Genomics and drug transporters and application in drug discovery, delivery and development.- Chapter 9. Genomics and drug metabolizing enzymes its application in Drug delivery: Evaluating the influence of the microbiome.- Chapter 10. Essentials of Genomics in the Continuum of Translational Research.- Chapter 11. Charting a coursefor genomic medicine from base pair to bedside.- Chapter 12. Pharmacogenomics and pharmacoepigenomics: impact on therapeutic strategies.- Chapter 13. Clinical Pharmacogenomics and Personalized Medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction.- Chapter 14. Epigenetic Patterns/Therapies associated with Genetic Disorders.- Chapter 15. Neurodegenerative disease conditions and genomic treatment for better health.- Chapter 16. Recent Trends in -Omics based methods and techniques for Lung Diseases prevention.- Chapter 17. Impact of Genomics on Personalization of Breast Cancer Care.- Chapter 18. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions.